HUP1700253A1 - Szilárd orális gyógyszerkészítmények - Google Patents
Szilárd orális gyógyszerkészítményekInfo
- Publication number
- HUP1700253A1 HUP1700253A1 HUP1700253A HUP1700253A1 HU P1700253 A1 HUP1700253 A1 HU P1700253A1 HU P1700253 A HUP1700253 A HU P1700253A HU P1700253 A1 HUP1700253 A1 HU P1700253A1
- Authority
- HU
- Hungary
- Prior art keywords
- oral administration
- solid preparations
- preparations
- solid
- oral
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1700253 HUP1700253A1 (hu) | 2017-06-13 | 2017-06-13 | Szilárd orális gyógyszerkészítmények |
TW107118464A TW201906608A (zh) | 2017-06-13 | 2018-05-30 | 口服固體製劑 |
KR1020207001040A KR20200016378A (ko) | 2017-06-13 | 2018-06-12 | 경구 투여를 위한 카리프라진의 고체 제제 |
CA3064694A CA3064694A1 (en) | 2017-06-13 | 2018-06-12 | Solid preparation of cariprazine for oral administration |
AU2018284138A AU2018284138A1 (en) | 2017-06-13 | 2018-06-12 | Solid preparation of cariprazine for oral administration |
EP18734306.6A EP3638210A1 (en) | 2017-06-13 | 2018-06-12 | Solid preparation of cariprazine for oral administration |
US16/622,020 US20200222391A1 (en) | 2017-06-13 | 2018-06-12 | Solid preparation of cariprazine for oral administration |
PCT/IB2018/054227 WO2018229641A1 (en) | 2017-06-13 | 2018-06-12 | Solid preparation of cariprazine for oral administration |
BR112019025214-2A BR112019025214A2 (pt) | 2017-06-13 | 2018-06-12 | Composição farmacêutica sólida administrável por via oral, uso da composição farmacêutica, processo para a preparação de composições farmacêuticas, e, método de tratamento de um paciente que sofre de condições patológicas |
ARP180101591A AR112137A1 (es) | 2017-06-13 | 2018-06-12 | Preparación sólida para administración oral que comprende cariprazina |
MX2019015206A MX2019015206A (es) | 2017-06-13 | 2018-06-12 | Preparacion solida de cariprazina para administracion oral. |
CN201880040070.6A CN110769815A (zh) | 2017-06-13 | 2018-06-12 | 口服的卡利拉嗪固体制剂 |
JP2019568138A JP2020523335A (ja) | 2017-06-13 | 2018-06-12 | 経口投与用固形製剤 |
PE2019002491A PE20200334A1 (es) | 2017-06-13 | 2018-06-12 | Preparacion solida para administracion oral |
EA202090029A EA202090029A1 (ru) | 2017-06-13 | 2018-06-12 | Твердая композиция карипразина для орального введения |
PH12019502566A PH12019502566A1 (en) | 2017-06-13 | 2019-11-15 | Pharmacologically active alicyclic-substituted pyrazolo[1,5-a] pyrimidine derivatives |
IL271108A IL271108A (en) | 2017-06-13 | 2019-12-02 | A solid preparation of cariprazine for oral administration |
CL2019003619A CL2019003619A1 (es) | 2017-06-13 | 2019-12-11 | Preparación sólida para administración oral. |
ZA2019/08454A ZA201908454B (en) | 2017-06-13 | 2019-12-18 | Solid preparation of cariprazine for oral administration |
CONC2020/0000168A CO2020000168A2 (es) | 2017-06-13 | 2020-01-09 | Preparación sólida de cariprazina para administración oral |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1700253 HUP1700253A1 (hu) | 2017-06-13 | 2017-06-13 | Szilárd orális gyógyszerkészítmények |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP1700253A1 true HUP1700253A1 (hu) | 2019-01-28 |
Family
ID=89992469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUP1700253 HUP1700253A1 (hu) | 2017-06-13 | 2017-06-13 | Szilárd orális gyógyszerkészítmények |
Country Status (20)
Country | Link |
---|---|
US (1) | US20200222391A1 (hu) |
EP (1) | EP3638210A1 (hu) |
JP (1) | JP2020523335A (hu) |
KR (1) | KR20200016378A (hu) |
CN (1) | CN110769815A (hu) |
AR (1) | AR112137A1 (hu) |
AU (1) | AU2018284138A1 (hu) |
BR (1) | BR112019025214A2 (hu) |
CA (1) | CA3064694A1 (hu) |
CL (1) | CL2019003619A1 (hu) |
CO (1) | CO2020000168A2 (hu) |
EA (1) | EA202090029A1 (hu) |
HU (1) | HUP1700253A1 (hu) |
IL (1) | IL271108A (hu) |
MX (1) | MX2019015206A (hu) |
PE (1) | PE20200334A1 (hu) |
PH (1) | PH12019502566A1 (hu) |
TW (1) | TW201906608A (hu) |
WO (1) | WO2018229641A1 (hu) |
ZA (1) | ZA201908454B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2317852T1 (sl) | 2008-07-16 | 2015-04-30 | Richter Gedeon Nyrt. | Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja |
US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
US11344503B2 (en) * | 2019-12-13 | 2022-05-31 | Halo Science LLC | Cariprazine release formulations |
CN114681406B (zh) * | 2020-12-25 | 2023-10-13 | 上海京新生物医药有限公司 | 一种卡利拉嗪长效缓释微球及其制备方法 |
CN114748428B (zh) * | 2020-12-25 | 2023-05-23 | 上海京新生物医药有限公司 | 一种高载药量的盐酸卡利拉嗪长效缓释微球及其制备方法 |
CN116675654A (zh) * | 2022-02-22 | 2023-09-01 | 上海云晟研新生物科技有限公司 | 卡利拉嗪药用盐及其晶型、药物组合物、制备方法和用途 |
US11931357B2 (en) | 2022-03-17 | 2024-03-19 | Mapi Pharma Ltd. | Depot systems comprising Cariprazine or salts thereof |
HUP2200312A1 (hu) * | 2022-08-05 | 2024-02-28 | Richter Gedeon Nyrt | Kariprazin tartalmú szájban diszpergálódó tabletta |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6248618A (ja) * | 1985-08-27 | 1987-03-03 | Zeria Shinyaku Kogyo Kk | 徐放性製剤およびその製造法 |
US5910319A (en) | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
HU227534B1 (en) | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
DK2185155T3 (en) * | 2007-08-03 | 2018-01-02 | Richter Gedeon Nyrt | PHARMACEUTICAL COMPOSITIONS WITH DOPAMINE RECEPTOR LIGANDS AND TREATMENT METHODS USING DOPAMINE RECEPTOR LIGANDS |
US20110059980A1 (en) * | 2008-02-21 | 2011-03-10 | Yasuaki Oobayashi | Solid preparation for oral administration |
SI2317852T1 (sl) * | 2008-07-16 | 2015-04-30 | Richter Gedeon Nyrt. | Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja |
EP3102190A4 (en) * | 2014-02-07 | 2017-09-06 | Auspex Pharmaceuticals, Inc. | Novel pharmaceutical formulations |
CN106692149A (zh) * | 2015-11-13 | 2017-05-24 | 天津市汉康医药生物技术有限公司 | 一种卡利拉嗪药物口服制剂及其制备方法 |
-
2017
- 2017-06-13 HU HUP1700253 patent/HUP1700253A1/hu unknown
-
2018
- 2018-05-30 TW TW107118464A patent/TW201906608A/zh unknown
- 2018-06-12 EP EP18734306.6A patent/EP3638210A1/en not_active Withdrawn
- 2018-06-12 AR ARP180101591A patent/AR112137A1/es unknown
- 2018-06-12 MX MX2019015206A patent/MX2019015206A/es unknown
- 2018-06-12 BR BR112019025214-2A patent/BR112019025214A2/pt not_active Application Discontinuation
- 2018-06-12 CN CN201880040070.6A patent/CN110769815A/zh active Pending
- 2018-06-12 PE PE2019002491A patent/PE20200334A1/es unknown
- 2018-06-12 JP JP2019568138A patent/JP2020523335A/ja active Pending
- 2018-06-12 AU AU2018284138A patent/AU2018284138A1/en not_active Abandoned
- 2018-06-12 CA CA3064694A patent/CA3064694A1/en not_active Abandoned
- 2018-06-12 WO PCT/IB2018/054227 patent/WO2018229641A1/en unknown
- 2018-06-12 US US16/622,020 patent/US20200222391A1/en not_active Abandoned
- 2018-06-12 KR KR1020207001040A patent/KR20200016378A/ko not_active Application Discontinuation
- 2018-06-12 EA EA202090029A patent/EA202090029A1/ru unknown
-
2019
- 2019-11-15 PH PH12019502566A patent/PH12019502566A1/en unknown
- 2019-12-02 IL IL271108A patent/IL271108A/en unknown
- 2019-12-11 CL CL2019003619A patent/CL2019003619A1/es unknown
- 2019-12-18 ZA ZA2019/08454A patent/ZA201908454B/en unknown
-
2020
- 2020-01-09 CO CONC2020/0000168A patent/CO2020000168A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2019003619A1 (es) | 2020-05-15 |
ZA201908454B (en) | 2021-10-27 |
PE20200334A1 (es) | 2020-02-14 |
CA3064694A1 (en) | 2018-12-20 |
JP2020523335A (ja) | 2020-08-06 |
KR20200016378A (ko) | 2020-02-14 |
WO2018229641A1 (en) | 2018-12-20 |
CN110769815A (zh) | 2020-02-07 |
AU2018284138A1 (en) | 2020-01-16 |
EP3638210A1 (en) | 2020-04-22 |
US20200222391A1 (en) | 2020-07-16 |
CO2020000168A2 (es) | 2021-06-21 |
TW201906608A (zh) | 2019-02-16 |
MX2019015206A (es) | 2020-02-10 |
EA202090029A1 (ru) | 2020-03-26 |
AR112137A1 (es) | 2019-09-25 |
IL271108A (en) | 2020-01-30 |
PH12019502566A1 (en) | 2020-07-20 |
BR112019025214A2 (pt) | 2020-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP1700253A1 (hu) | Szilárd orális gyógyszerkészítmények | |
IL270812A (en) | Solid compositions for oral drug administration | |
ZA201903101B (en) | Pharmaceutical formulations | |
IL262745A (en) | Improved preparations containing drugs | |
ZA202006570B (en) | Pharmaceutical formulations | |
HK1248544A1 (zh) | 穩定的口服給藥用藥物組合物 | |
IL262204A (en) | Granular formulation for oral administration | |
IL285674A (en) | Pharmaceutical formulations | |
HK1245646A1 (zh) | 口服給藥用醫藥組合物 | |
HUE062551T2 (hu) | Kapszulás készítmények | |
ZA202006346B (en) | Pharmaceutical preparation | |
SI3996688T1 (sl) | Farmacevtski preparat | |
IL271908A (en) | Over-compressed pharmaceutical preparations | |
SG11202010792TA (en) | Improved pharmaceutical formulations | |
HK1232144A1 (zh) | 經口給藥用醫藥組合物 | |
LT3377044T (lt) | Ibuprofeno kompozicijos, skirtos tiesioginiam peroraliniam įvedimui | |
EP3512507A4 (en) | ORAL MEDICINAL FORMULATIONS | |
GB201610440D0 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |